Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	New Amedeo service: Amedeo COVID-19 (formerly 2019-nCoV) Weekly publication summary

Head and Neck Cancer

Free Subscription 03.02.2020 1 Ann Thorac Surg 2 BMC Cancer 1 BMC Surg 1 Cancer 1 Clin Cancer Res 2 Clin Nucl Med 8 Dis Esophagus 1 Gastrointest Endosc 3 Head Neck 4 HNO 2 Int J Cancer 1 Int J Pediatr Otorhinolaryngol 7 Int J Radiat Oncol Biol Phys 5 Laryngoscope 8 Ophthalmic Plast Reconstr Surg 4 Oral Oncol 13 Otolaryngol Head Neck Surg 2 PLoS One 1 Radiology 1 Radiother Oncol 1 Surgery 1 Thyroid

Retrieve available abstracts of this week’s articles: HTML format Text format

Single Articles

Ann Thorac Surg

1. ZHAO Y, Chen D, Wang W, Zhao T, et al
   Significance of TIM-3 Expression in Resected Esophageal Squamous Cell Carcinoma.
   Ann Thorac Surg. 2020 Jan 24. pii: S0003-4975(20)30067.
   PubMed     Text format     Abstract available
   
   

   
   BMC Cancer

2. SU HA, Hsiao SW, Hsu YC, Wang LY, et al
   Superiority of NBI endoscopy to PET/CT scan in detecting esophageal cancer among head and neck cancer patients: a retrospective cohort analysis.
   BMC Cancer. 2020;20:69.
   PubMed     Text format     Abstract available
   
   
3. GOMEZ-ACEVEDO H, Patterson JD, Sardar S, Gokden M, et al
   SMARC-B1 deficient sinonasal carcinoma metastasis to the brain with next generation sequencing data: a case report of perineural invasion progressing to leptomeningeal invasion.
   BMC Cancer. 2019;19:827.
   PubMed     Text format     Abstract available
   
   

   
   BMC Surg

4. HOSHINO I, Gunji H, Ishige F, Iwatate Y, et al
   Surgical treatment strategy for esophagogastric junction cancers based on the tumor diameter.
   BMC Surg. 2019;19:152.
   PubMed     Text format     Abstract available
   
   

   
   Cancer

5. LIN TA, Garden AS, Elhalawani H, Elgohari B, et al
   Radiographic retropharyngeal lymph node involvement in HPV-associated oropharyngeal carcinoma: Patterns of involvement and impact on patient outcomes.
   Cancer. 2019;125:1536-1546.
   PubMed     Text format     Abstract available
   
   

   
   Clin Cancer Res

6. LU G, Fakurnejad S, Martin BA, van den Berg NS, et al
   Predicting Therapeutic Antibody Delivery into Human Head and Neck Cancers.
   Clin Cancer Res. 2020 Jan 24. pii: 1078-0432.CCR-19-3717.
   PubMed     Text format     Abstract available
   
   

   
   Clin Nucl Med

7. LIM CH, Park YJ, Shin M, Cho YS, et al
   Tumor SUVs on 18F-FDG PET/CT and Aggressive Pathological Features in Esophageal Squamous Cell Carcinoma.
   Clin Nucl Med. 2020;45:e128-e133.
   PubMed     Text format     Abstract available
   
   
8. TARALLI S, Lorusso M, Capotosti A, Lanni V, et al
   Which Is the Optimal Scan Time of 18F-DOPA PET/CT in Patients With Recurrent Medullary Thyroid Carcinoma?: Results From a Dynamic Acquisition Study.
   Clin Nucl Med. 2020;45:e134-e140.
   PubMed     Text format     Abstract available
   
   

   
   Dis Esophagus

9. GENTILE D, Riva P, Da Roit A, Basato S, et al
   Gastric tube cancer after esophagectomy for cancer: a systematic review.
   Dis Esophagus. 2019;32.
   PubMed     Text format     Abstract available
   
   
10. FUJIWARA H, Kanamori J, Nakajima Y, Kawano T, et al
    An anatomical hypothesis: a "concentric-structured model" for the theoretical understanding of the surgical anatomy in the upper mediastinum required for esophagectomy with radical mediastinal lymph node dissection.
    Dis Esophagus. 2019;32.
    PubMed     Text format     Abstract available
    
    
11. KINGMA BF, Visser E, Marsman M, Ruurda JP, et al
    Epidural analgesia after minimally invasive esophagectomy: efficacy and complication profile.
    Dis Esophagus. 2019;32.
    PubMed     Text format     Abstract available
    
    
12. YANG GQ, Mhaskar R, Rishi A, Naghavi AO, et al
    Intensity-modulated radiotherapy at high-volume centers improves survival in patients with esophageal adenocarcinoma receiving trimodality therapy.
    Dis Esophagus. 2019;32.
    PubMed     Text format     Abstract available
    
    
13. CALLAHAN ZM, Shi Z, Su B, Xu J, et al
    Genetic variants in Barrett's esophagus and esophageal adenocarcinoma: a literature review.
    Dis Esophagus. 2019;32.
    PubMed     Text format     Abstract available
    
    
14. SOROUSH A, Poneros JM, Lightdale CJ, Abrams JA, et al
    Shorter time to achieve endoscopic eradication is not associated with improved long-term outcomes in Barrett's esophagus.
    Dis Esophagus. 2019;32.
    PubMed     Text format     Abstract available
    
    
15. WIETHALER M, Slotta-Huspenina J, Brandtner A, Horstmann J, et al
    BarrettNET-a prospective registry for risk estimation of patients with Barrett's esophagus to progress to adenocarcinoma.
    Dis Esophagus. 2019;32.
    PubMed     Text format     Abstract available
    
    
16. HOELSCHER A
    ISDE presidential biography: J R Siewert.
    Dis Esophagus. 2019;32.
    PubMed     Text format    
    
    

    
    Gastrointest Endosc

17. DUA KS, DeWitt JM, Kessler WR, Diehl DL, et al
    A phase III, multicenter, prospective, single-blinded, noninferiority, randomized controlled trial on the performance of a novel esophageal stent with an antireflux valve (with video).
    Gastrointest Endosc. 2019;90:64-74.
    PubMed     Text format     Abstract available
    
    

    
    Head Neck

18. RATURI V, Hojo H, Bhatt MLB, Suhel M, et al
    Prospective evaluation of XRCC-1 Arg194Trp polymorphism as bio-predictor for clinical outcome in locally advanced laryngeal cancer undergoing cisplatin-based chemoradiation.
    Head Neck. 2020 Jan 30. doi: 10.1002/hed.26083.
    PubMed     Text format     Abstract available
    
    
19. SWIECICKI PL, Li P, Bellile E, Stucken C, et al
    Paired phase II trials evaluating cetuximab and radiotherapy for low risk HPV associated oropharyngeal cancer and locoregionally advanced squamous cell carcinoma of the head and neck in patients not eligible for cisplatin.
    Head Neck. 2020 Jan 27. doi: 10.1002/hed.26085.
    PubMed     Text format     Abstract available
    
    
20. LIU YP, Xie YL, Zou X, You R, et al
    Techniques of endoscopic nasopharyngectomy for localized stage I nasopharyngeal carcinoma.
    Head Neck. 2020 Jan 24. doi: 10.1002/hed.26090.
    PubMed     Text format     Abstract available
    
    

    
    HNO

21. QIAN X, Leonard F, Wenhao Y, Sudhoff H, et al
    Immunotherapeutics for head and neck squamous cell carcinoma stem cells.
    HNO. 2020 Jan 29. pii: 10.1007/s00106-020-00819.
    PubMed     Text format     Abstract available
    
    
22. STRIETH S, Hagemann J, Hess M
    [Angiolytic laser applications for the larynx : Phonosurgical concepts for transoral laser microsurgery].
    HNO. 2020;68:59-68.
    PubMed     Text format     Abstract available
    
    
23. VOLKER HU, Becker E, Muller-Hermelink HK, Scheich M, et al
    [Extranodal manifestation of classical Hodgkin lymphoma in the head and neck region].
    HNO. 2020;68:32-39.
    PubMed     Text format     Abstract available
    
    
24. SUDHOFF H, Gehl HB, Brasch F, Riemann R, et al
    [A rare pathology of the petrous part of the temporal bone: adenoma of the middle ear].
    HNO. 2019 Sep 17. pii: 10.1007/s00106-019-00753.
    PubMed     Text format     Abstract available
    
    

    
    Int J Cancer

25. DOGAN S, Xu B, Middha S, Vanderbilt CM, et al
    Identification of Prognostic Molecular Biomarkers in 157 HPV-positive and HPV-negative Squamous Cell Carcinomas of the Oropharynx.
    Int J Cancer. 2019 May 16. doi: 10.1002/ijc.32412.
    PubMed     Text format     Abstract available
    
    
26. BORNSCHEIN J, Wernisch L, Secrier M, Miremadi A, et al
    Transcriptomic profiling reveals three molecular phenotypes of adenocarcinoma at the gastroesophageal junction.
    Int J Cancer. 2019;145:3389-3401.
    PubMed     Text format     Abstract available
    
    

    
    Int J Pediatr Otorhinolaryngol

27. WOLTER NE, Ngan B, Whitlock JA, Dickson BC, et al
    Atypical juvenile histiocytosis with novel KIF5B-ALK gene fusion mimicking subglottic hemangioma.
    Int J Pediatr Otorhinolaryngol. 2019;126:109585.
    PubMed     Text format     Abstract available
    
    

    
    Int J Radiat Oncol Biol Phys

28. BOUSTANI J, Rivin Del Campo E, Blanc J, Peiffert D, et al
    Quality Assurance of Dose-Escalated Radiation Therapy in a Randomized Trial for Locally Advanced Oesophageal cancer.
    Int J Radiat Oncol Biol Phys. 2019;105:329-337.
    PubMed     Text format     Abstract available
    
    
29. ZHOU S, Yang H, Zhang J, Wang J, et al
    Changes in indoleamine 2,3-dioxygenase 1 expression and CD8+ tumor-infiltrating lymphocytes after neoadjuvant chemoradiotherapy and prognostic significance in esophageal squamous cell carcinoma.
    Int J Radiat Oncol Biol Phys. 2020 Jan 28. pii: S0360-3016(20)30126.
    PubMed     Text format     Abstract available
    
    
30. BORGGREVE AS, Goense L, van Rossum PSN, Heethuis SE, et al
    Preoperative prediction of pathologic response to neoadjuvant chemoradiotherapy in patients with esophageal cancer using (18)F-FDG PET/CT and DW-MRI: a prospective multicenter study.
    Int J Radiat Oncol Biol Phys. 2020 Jan 24. pii: S0360-3016(20)30052.
    PubMed     Text format     Abstract available
    
    
31. CHOU WC, Chang PH, Chen PT, Wang HM, et al
    Clinical Significance of Vulnerability Assessment in Patients with Primary Head and Neck Cancer Undergoing Definitive Concurrent Chemoradiotherapy.
    Int J Radiat Oncol Biol Phys. 2020 Jan 24. pii: S0360-3016(20)30057.
    PubMed     Text format     Abstract available
    
    
32. LIU C, Patel SH, Shan J, Schild SE, et al
    Robust Optimization for Intensity-Modulated Proton Therapy to Redistribute High Linear Energy Transfer (LET) from Nearby Critical Organs to Tumors in Head and Neck Cancer.
    Int J Radiat Oncol Biol Phys. 2020 Jan 24. pii: S0360-3016(20)30072.
    PubMed     Text format     Abstract available
    
    
33. VERBAKEL WFAR, Doornaert PAH, Raaijmakers CPJ, Bos LJ, et al
    Targeted Intervention to Improve the Quality of Head and Neck Radiation Therapy Treatment Planning in the Netherlands: Short and Long-Term Impact.
    Int J Radiat Oncol Biol Phys. 2019;105:514-524.
    PubMed     Text format     Abstract available
    
    
34. LI J, Wang L, Zhang X, Liu L, et al
    Machine Learning for Patient-Specific Quality Assurance of VMAT: Prediction and Classification Accuracy.
    Int J Radiat Oncol Biol Phys. 2019;105:893-902.
    PubMed     Text format     Abstract available
    
    

    
    Laryngoscope

35. VARELAS AN, Ganti A, Eggerstedt M, Tajudeen BA, et al
    Prognostic indicators of survival in sinonasal extranodal natural killer/T-cell lymphoma.
    Laryngoscope. 2019;129:2675-2680.
    PubMed     Text format     Abstract available
    
    
36. MOHAMMED H, Del Pero M, Coates M, Masterson L, et al
    Office-based transnasal esophagoscopy biopsies for histological diagnosis of head and neck patients.
    Laryngoscope. 2019;129:2721-2726.
    PubMed     Text format     Abstract available
    
    
37. O'DELL K, Hubanks J
    In-Office Injection Pharyngoplasty for Velopharyngeal Insufficiency After Oropharyngeal Cancer Treatment.
    Laryngoscope. 2019;129:2740-2743.
    PubMed     Text format    
    
    
38. PURAM SV, Bhattacharyya N
    Surgery versus radiation for T1 glottic carcinoma: Second primary considerations.
    Laryngoscope. 2019;129:2713-2715.
    PubMed     Text format     Abstract available
    
    
39. SAMUELS TL, Altman KW, Gould JC, Kindel T, et al
    Esophageal pepsin and proton pump synthesis in barrett's esophagus and esophageal adenocarcinoma.
    Laryngoscope. 2019;129:2687-2695.
    PubMed     Text format     Abstract available
    
    

    
    Ophthalmic Plast Reconstr Surg

40. ALSHAKER S, Jivraj I, Chen H, Muthusami P, et al
    Management of a Large Congenital Hemangioma Obstructing Visual Axis: A Case Report and Review of Literature.
    Ophthalmic Plast Reconstr Surg. 2019;35:e154-e157.
    PubMed     Text format     Abstract available
    
    
41. ULLRICH K, Bisase B, Kumar S, Malhotra R, et al
    Maintaining Quality of Life: Electrochemotherapy for Palliative Periorbital Malignancy.
    Ophthalmic Plast Reconstr Surg. 2019;35:e138-e142.
    PubMed     Text format     Abstract available
    
    
42. CHARLES NC, Patel P
    Solid Variant of a Proliferative Apocrine Hidrocystoma.
    Ophthalmic Plast Reconstr Surg. 2019;35:e72-e74.
    PubMed     Text format     Abstract available
    
    
43. KASTURI N, Chavhan P, Ramakant GG, Devaraj A, et al
    Conjunctival Trichodiscoma of the Lower Eyelid.
    Ophthalmic Plast Reconstr Surg. 2019 Sep 27. doi: 10.1097/IOP.0000000000001470.
    PubMed     Text format     Abstract available
    
    
44. DESJARLAIS EB, Jovanovic N, Teo HMT, Kahana A, et al
    Surgical Management of a Recurrent Orbit-Eroding Mucocele Associated With Frontal-Ethmoidal Sinus Inverted Papilloma.
    Ophthalmic Plast Reconstr Surg. 2019;35:e136-e138.
    PubMed     Text format     Abstract available
    
    
45. SCOFIELD-KAPLAN SM, Jackson C, Gurney T, McDonnell E, et al
    Predictive Value of Preoperative Periocular Skin Cancer Measurements for Final Mohs Defect Size.
    Ophthalmic Plast Reconstr Surg. 2019;35:604-608.
    PubMed     Text format     Abstract available
    
    
46. KAPOOR AG, V S V, Mittal R
    Trichofolliculoma of the Eyelid Margin: A Case Report and Review of Literature.
    Ophthalmic Plast Reconstr Surg. 2019 Mar 22. doi: 10.1097/IOP.0000000000001363.
    PubMed     Text format     Abstract available
    
    
47. KO MJ, Erickson BP, Blessing NW, Tse DT, et al
    The Flip-Back Myocutaneous Advancement Flap for Periocular Reconstruction.
    Ophthalmic Plast Reconstr Surg. 2019;35:569-573.
    PubMed     Text format     Abstract available
    
    

    
    Oral Oncol

48. GRUNWALD V, Chirovsky D, Cheung WY, Bertolini F, et al
    Global treatment patterns and outcomes among patients with recurrent and/or metastatic head and neck squamous cell carcinoma: Results of the GLANCE H&N study.
    Oral Oncol. 2020;102:104526.
    PubMed     Text format     Abstract available
    
    
49. SHARMA N, Fagan J, Wallace M, Joubert E, et al
    Prioritisation of research topics for head and neck cancer in Africa - Report of the International Collaboration On Improving Cancer outcomes in low and middle income countries - ICOnIC Africa.
    Oral Oncol. 2020 Jan 21:104503. doi: 10.1016/j.oraloncology.2019.104503.
    PubMed     Text format    
    
    
50. HORN D, Zittel S, Moratin J, Metzger K, et al
    Prospective feasibility analysis of salvage surgery in recurrent oral cancer in terms of quality of life.
    Oral Oncol. 2020;102:104580.
    PubMed     Text format     Abstract available
    
    
51. PEIGNE L, Godey F, Le Gallo M, Le Gall F, et al
    One-step nucleic acid amplification for detecting lymph node metastasis of head and neck squamous cell carcinoma.
    Oral Oncol. 2020;102:104553.
    PubMed     Text format     Abstract available
    
    

    
    Otolaryngol Head Neck Surg

52. ZENGA J, Graboyes E, Janz T, Drake V, et al
    Salvage of Recurrence after Surgery and Adjuvant Therapy: A Multi-institutional Study.
    Otolaryngol Head Neck Surg. 2019;161:74-81.
    PubMed     Text format     Abstract available
    
    
53. OLIVER J, Wu P, Chang C, Roden D, et al
    Patterns of Care and Outcome of Clear Cell Carcinoma of the Head and Neck.
    Otolaryngol Head Neck Surg. 2019;161:98-104.
    PubMed     Text format     Abstract available
    
    
54. DUNDAR Y, Mandle Q, Raza SN, Lin HS, et al
    Submandibular Gland Invasion by Oral Cavity Cancers: A Systematic Review.
    Otolaryngol Head Neck Surg. 2019;161:227-234.
    PubMed     Text format     Abstract available
    
    
55. BULBUL MG, Tarabichi O, Sethi RK, Parikh AS, et al
    Does Clearance of Positive Margins Improve Local Control in Oral Cavity Cancer? A Meta-analysis.
    Otolaryngol Head Neck Surg. 2019;161:235-244.
    PubMed     Text format     Abstract available
    
    
56. JONES EA, Shuman AG, Egleston BL, Liu JC, et al
    Common Pitfalls of Head and Neck Research Using Cancer Registries.
    Otolaryngol Head Neck Surg. 2019;161:245-250.
    PubMed     Text format     Abstract available
    
    
57. DU E, Farzal Z, Stephenson E, Tanner A, et al
    Multimodal Analgesia Protocol after Head and Neck Surgery: Effect on Opioid Use and Pain Control.
    Otolaryngol Head Neck Surg. 2019;161:424-430.
    PubMed     Text format     Abstract available
    
    
58. ABDELWAHAB M, Overdevest JB, Elmokadem A, El-Sisi H, et al
    Nasopharyngeal Angiofibroma Staging with a Novel Nominal Basis: An 18-Year Study in a Tertiary Center.
    Otolaryngol Head Neck Surg. 2019;161:352-361.
    PubMed     Text format     Abstract available
    
    
59. COHEN DS, Tongson-Ignacio JE, Lolachi CM, Ghaderi VS, et al
    Rethinking Malignancy Risk in Indeterminate Thyroid Nodules with Positive Molecular Studies: Southern California Permanente Experience.
    Otolaryngol Head Neck Surg. 2019;161:419-423.
    PubMed     Text format     Abstract available
    
    
60. STUBBS VC, Jaffe S, Rajasekaran K, Cannady SB, et al
    Intraoperative Imaging with Second Window Indocyanine Green for Head and Neck Lesions and Regional Metastasis.
    Otolaryngol Head Neck Surg. 2019;161:539-542.
    PubMed     Text format     Abstract available
    
    
61. APPACHI S, Shah J, Reddy C, Bowen A, et al
    Analysis of Process-Related Quality Metrics and Survival of Patients with Oral Cavity Squamous Cell Carcinoma.
    Otolaryngol Head Neck Surg. 2019;161:450-457.
    PubMed     Text format     Abstract available
    
    
62. GROSS JH, Zenga J, Sharon JD, Jackson RS, et al
    Longus Capitis Reconstruction of the Soft Palate.
    Otolaryngol Head Neck Surg. 2019;161:536-538.
    PubMed     Text format     Abstract available
    
    
63. TOWNSEND M, DeWees T, Gross J, Daly M, et al
    Timing of Postoperative Radiotherapy in Surgically Treated HPV-Positive Oropharyngeal Squamous Cell Carcinoma.
    Otolaryngol Head Neck Surg. 2019;161:297-306.
    PubMed     Text format     Abstract available
    
    
64. BOOTH JR, Unsal AA, Tadros S, Byrd JK, et al
    Salivary Gland Cancers of the Nasopharynx: A Population-Based Analysis of 383 Cases.
    Otolaryngol Head Neck Surg. 2019;161:442-449.
    PubMed     Text format     Abstract available
    
    

    
    PLoS One

65. LIU H, Zhao J, Fu R, Zhu C, et al
    The ginsenoside Rk3 exerts anti-esophageal cancer activity in vitro and in vivo by mediating apoptosis and autophagy through regulation of the PI3K/Akt/mTOR pathway.
    PLoS One. 2019;14:e0216759.
    PubMed     Text format     Abstract available
    
    
66. ZHOU J, Zhang J, Xu M, Ke Z, et al
    High SRC-1 and Twist1 expression predicts poor prognosis and promotes migration and invasion by inducing epithelial-mesenchymal transition in human nasopharyngeal carcinoma.
    PLoS One. 2019;14:e0215299.
    PubMed     Text format     Abstract available
    
    

    
    Radiology

67. YEH R, Tay YD, Tabacco G, Dercle L, et al
    Diagnostic Performance of 4D CT and Sestamibi SPECT/CT in Localizing Parathyroid Adenomas in Primary Hyperparathyroidism.
    Radiology. 2019 Mar 3:182122. doi: 10.1148/radiol.2019182122.
    PubMed     Text format     Abstract available
    
    

    
    Radiother Oncol

68. DE KRUIJF W, Timmers A, Dekker J, Boing-Messing F, et al
    Occurrence and mechanism of visual phosphenes in external photon beam radiation therapy and how to influence them.
    Radiother Oncol. 2019;132:109-113.
    PubMed     Text format     Abstract available
    
    

    
    Surgery

69. ZOLIN SJ, Burneikis T, Rudin AV, Shirley RB, et al
    Analysis of a thyroid nodule care pathway: Opportunity to improve compliance and value of care.
    Surgery. 2019 Aug 8. pii: S0039-6060(19)30356-3. doi: 10.1016/j.surg.2019.
    PubMed     Text format     Abstract available
    
    

    
    Thyroid

70. TRIMBOLI P, Piccardo A, Signore A, Valabrega S, et al
    Patient age is an independent risk factor of relapse of differentiated thyroid carcinoma and improves the performance of the ATA stratification system.
    Thyroid. 2020 Jan 23. doi: 10.1089/thy.2019.0688.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Head and Neck Cancer is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: